title: Should we take into account ESBLs in empirical antibiotic treatment?
authors: Infectious Diseases Division, Santa Maria Misericordia University Hospital, Udine, Italy. mattba@tin.it.|Clinica Malattie Infettive, Azienda Ospedaliero-Universitaria "Santa Maria Della Misericordia", Piazzale S. Maria Della Misericordian. 15, 33100, Udine, Italy. mattba@tin.it.
authors: Matteo
authors: 0000-0002-4406-962X
authors: M
authors: Bassetti
authors: Unidad Clínica Intercentros de Enfermedades Infecciosas, Microbiología Y Medicina Preventiva, Hospitales Universitarios Virgen Macarena Y Virgen Del Rocío-IbiS and Departamento de Medicina, Universidad de Sevilla, Seville, Spain.
authors: Jesús
authors: J
authors: Rodríguez-Baño
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016638:Critical Illness; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D006090:Gram-Negative Bacteria / Q000187:drug effects*; D006801:Humans; D012307:Risk Factors; D018440:beta-Lactam Resistance / Q000187:drug effects*; D065093:beta-Lactamase Inhibitors / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D065093:beta-Lactamase Inhibitors